Since 1992 the Section of Urology at The University of Chicago has excelled under the leadership of Dr. Charles Brendler and recently Dr. Arieh Shalhav. Our current team includes nine highly skillful and experienced full time surgical faculty members, and two outstanding full time research faculty members. Our team also includes eight clinical and four research affiliated faculty members. We are now the leading institution in Illinois in minimally invasive management of urological cancer and benign urologic disease. We offer national expertise in urological cancer, robotic and laparoscopic urological surgery, prostate disease, female urology, reconstructive surgery, stone disease, and pediatric urology. Over the past decade, our surgical volume has quadrupled. Our team offers a unique concept in which each one of us focuses on a narrow aspect of our field. This allows superior specialization in different urological diseases providing unparalleled personal experience and expertise for our patients.
We are also dedicated to discovery. The major focus and effort of our laboratories is to identify genes which regulate the spread of cancer cells, develop better and less invasive treatments for patients with urologic cancer, identify nutritional and environmental factors that may promote or prevent cancer, as well as understand the interactions of the urinary bladder with the nervous system. Our basic science team includes: faculty members, post-doctoral fellows, and graduate students.
Through our commitment to education every year we have three residents graduate our urology residency program, one or two fellows graduate our minimally invasive fellowship and surgical urology program. Most of our graduates choose to pursue academic and leadership careers.
The mission of the Section of Urology at the
We seek to achieve these goals through a graceful, collegial team approach, fulfilling our legacy at the forefront of medicine.
I welcome you to browse our website.
Arieh L. Shalhav, M.D.